With 3.96 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.71 million shares. The 52-week range on HUMA shows that it touched its highest point at $9.97 and its lowest point at $1.15 during that stretch. It currently has a 1-year price target of $11.43. Beta for the stock currently stands at 1.63.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HUMA was down-trending over the past week, with a drop of -13.99%, but this was down by -8.89% over a month. Three-month performance dropped to -71.85% while six-month performance fell -75.64%. The stock lost -72.05% in the past year, while it has lost -75.64% so far this year. A look at the trailing 12-month EPS for HUMA yields -1.26 with Next year EPS estimates of -0.30. For the next quarter, that number is -0.19. This implies an EPS growth rate of 42.00% for this year and 58.32% for next year.
Float and Shares Shorts:
At present, 130.03 million HUMA shares are outstanding with a float of 125.75 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HUMA since 2 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.05626 being high and -$1.4937 being low. For HUMA, this leads to a yearly average estimate of -$1.355.
